Market Intelligence

Access the latest earnings reports, market analysis, hot topics, and individual stock insights

Report Categories

View All

Recent Articles

View All
Is Rgc Resources Rgco Stock Rebounding Price At 21.72 Up 0.32 20260402 Daily Market Overview S And P 500 Nasdaq Rise Slightly Dow Dips In Mixed Trade 20260403 1 Is Gorilla Grrr Stock Near Resistance Price At 10.84 Down 3.04 20260406 Daily Market Overview Sp 500 And Nasdaq Edge Higher Dow Dips Slightly 20260408 1 Is Golar Lng Glng Stock A Top Performer Price At 55.93 Up 1.16 20260406 SLSR Solaris Resources Inc Common Shares posts narrower Q4 2025 loss than estimates shares dip 088 percent in todays trading The reasons Ecovyst ECVT could be underpriced Under Pressure 20260507 DOLE Dole reports 82 percent revenue growth in Q1 shares rise 054 percent PriceSmart PSMT Stock Is It Undervalued Investors Pile In 20260418 United Parcel Service Inc UPS Bearish NearTerm Outlook Amid Kevin Warsh Fed Chair Nomination Is White WTM stock undervalued relative to performance Q2 2025 EPS Misses Views Highwoods Properties HIW Stock Is It a Strong Investment Pick Q4 2025 Earnings Beat Estimates Matthews MATW Stock Take Exposure Marginal Loss 20260420 ANTX AN2 Thera reports wider than expected Q4 2025 loss shares rise slightly on positive investor sentiment WD Walker and Q4 2025 EPS misses estimates by 132 percent shares drop 082 percent in todays trade How Pediatrix MD earnings track against industry trends Q1 2026 Profit Exceeds Views Why are smart money investors paying attention to Wheels Up UP Rocket Higher 20260505 How Inspira IINN compares to the market average Breakdown Watch 20260506 How Arista ANET is solving the problems its peers cannot Neutral 20260505 New Study Links LowDose Finasteride to Erectile Dysfunction Risk Potentially Affecting Prescribing Patterns Roadzen RDZN Q1 2026 Results Miss Estimates EPS 012 vs 003 NewAmsterdam NAMSW Trading at 2731 Key Decision Point 20260515 USIran Tensions Escalate as Ceasefire Deadline Nears Raising Stakes for Peace Talks Shopees AIDriven Growth Fuels Sea Limiteds Record Q1 Revenue Surge Dollar Gains Momentum as Flight to Quality Drives SafeHaven Demand Analyst Report Amgen Inc New Coverage Highlights Biotech Positioning Olaplex Holdings OLPX Reports Strong Q1 2026 Revenue NA EPS Beats Geopolitical Tensions Rise as US Military Flights Tracked Near Cuba Market Implications Saratoga Investment Corp SAV Q1 2026 Earnings Surprise EPS Miss Weighs on Sentiment Notes Edge Higher Ubisoft Shares Slide as Assassins Creed Maker Warns of Continued Losses Julong Holdings JLHL Tumbles 109 as Selling Pressure Intensifies Cigna Group CI Draws Analyst Upgrade Amid Dividend Growth and Managed Care Tailwinds Borosil Glass Works Shares Surge Over 200 in a Year on Strong Revenue Growth 30 Nifty Stocks Wipe Out Rs 2264 Lakh Crore in Investor Wealth This Year HDFC Bank and TCS Lead Decline BP Shares Decline Following Abrupt Removal of Chairman Albert Manifold Rising Gas Prices Disproportionately Impact LowIncome Households New York Fed Study Indicates EM Q2 2024 Earnings Stellar EPS Surprise of 42957 AbbVie ABBV Q1 2026 Earnings Slight EPS Beat Amid Solid Operational Execution SXT Q1 2026 Earnings Strong EPS Beat Drives Positive Sentiment ABEO Q1 2026 Earnings NarrowerthanExpected Loss Bolstered by Cost Management ADC Therapeutics Q1 2026 Earnings Narrower Loss Beats Expectations as Pipeline Progress Continues Bleichroeder Acquisition Corp II BBCQ Edges Higher SPAC Stock Shows Modest Uptick Chemours CC Surges 34 as Support Holds Key Resistance Ahead Anavex Life Sciences AVXL Edges Lower Hovering Near Key Support Cellectis CLLS Slides 127 as Biotech Struggles to Hold Above Key Support Is Deckers DECK stock under risk pressure Q1 2026 EPS Exceeds Expectations LNSR LENSAR posts mixed Q4 2025 results as yearoveryear revenue growth offsets steep earnings miss stock edges modestly higher Vanguard Information Technology ETF VGT Among 5 Vanguard LowCost Index ETFs Executing 2026 Forward Splits Effective April 21 Is Evogene EVGN stock worth starting a position in Technical Weakness 20260420 Regeneron Pharmaceuticals REGN Competitive Risks Rise as ANIPs Specialty Drug Growth Disrupts Core Ophthalmology Segments